Specification and Evaluation of Plasticizer Migration Simulants for Human Blood Products: A Delphi Study

• Published in: Biomolecules (Basel, Switzerland) Switzerland), 2021-07, Vol.11 (8), p.1081
• Main Authors: Thelliez, Aurélie, Hénard, Grégory, Delorme, Bruno, Chatellier, Sonia, Danel, Cécile, Ducoroy, Laurent, Dupont, Annabelle, Garrigue, Delphine, Genay, Stéphanie, Goossens, Jean-François, Goossens, Laurence, Havet, Coralie, Hecq, Jean-Daniel, Maeght, Caroline, Mendel, Isabelle, Najdovski, Tomé, Odou, Pascal, Saint-Lorant, Guillaume, Ung, Alexandre, Lecoeur, Marie, Décaudin, Bertrand
• Format: Article
• Language: English
• Subjects: Blood products; Delphi method; Erythrocytes; labile blood product; Life Sciences; Literature reviews; Medical equipment; migration; Natural products; plasticizer; Polyvinyl chloride; Questionnaires; simulant
• ISSN: 2218-273X; 2218-273X
• DOI: 10.3390/biom11081081

Potentially toxic plasticizers are commonly added to polyvinyl chloride medical devices for transfusion in order to improve their flexibility and workability. As the plasticizers are not chemically bonded to the PVC, they can be released into labile blood products (LBPs) during storage. Ideally, LBPs would be used in laboratory studies of plasticizer migration from the medical device. However, short supply (i.e., limited stocks of human blood in collection centres) has prompted the development of specific simulants for each type of LBP in the evaluation of new transfusion devices. We performed a Delphi study with a multidisciplinary panel of 24 experts. In the first (qualitative) phase, the panel developed consensus definitions of the specification criteria to be met by each migration simulant. Next, we reviewed the literature on techniques for simulating the migration of plasticizers into LBPs. A questionnaire was elaborated and sent out to the experts, and the replies were synthesized in order to obtain a consensus. The qualitative study established specifications for each biological matrix (whole blood, red blood cell concentrate, plasma, and platelet concentrate) and defined the criteria required for a suitable LBP simulant. Ten criteria were suggested: physical and chemical characteristics, opacity, form, stability, composition, ability to mimic a particular clinical situation, ease and safety of use, a simulant–plastic interaction correlated with blood, and compatibility with analytical methods. The questionnaire data revealed a consensus on the use of natural products (such as pig’s blood) to mimic the four LBPs. Opinions diverged with regard to synthetic products. However, an isotonic solution and a rheological property modifier were considered to be of value in the design of synthetic simulants. Consensus reached by the Delphi group could be used as a database for the development of simulants used to assess the migration of plasticizers from PVC bags into LBPs.